Leavitt Bruce J, Ross Cathy S, Spence Brian, Surgenor Stephen D, Olmstead Elaine M, Clough Robert A, Charlesworth David C, Kramer Robert S, O'Connor Gerald T
Fletcher Allen Health Care, 111 Colchester Ave, Burlington, VT 05401-1473, USA.
Circulation. 2006 Jul 4;114(1 Suppl):I430-4. doi: 10.1161/CIRCULATIONAHA.105.000943.
Chronic obstructive pulmonary disease (COPD) is associated with increased in-hospital mortality in patients undergoing coronary artery bypass surgery (CABG). Long-term survival is less well understood. The present study examined the effect of COPD on survival after CABG.
We conducted a prospective study of 33,137 consecutive isolated CABG patients between 1992 and 2001 in northern New England. Records were linked to the National Death Index for long-term mortality data. Cox proportional hazards regression was used to calculate hazard ratios (HRs). Patients were stratified by: no comorbidities (none), COPD, COPD plus comorbidities, and other comorbidities with no COPD. There were 131,434 person years of follow-up and 5344 deaths. The overall incidence rate (deaths per 100 person years) was 4.1. By group, rates were: 2.1 (none), 4.0 (COPD alone), 5.5 (other), and 9.4 (COPD plus; log rank P<0.001). After adjustment, survival with COPD alone was worse compared with none (HR, 1.8; 95% CI, 1.6 to 2.1; P<0.001). Patients with other comorbidities compared with none had even worse survival (HR, 2.2; 95% CI, 2.1 to 2.4; P<0.001). Patients with COPD plus other comorbidities compared with none had the worst long-term survival (HR, 3.6; 95% CI, 3.3 to 3.9; P<0.001).
Patients with only COPD had significantly reduced long-term survival compared with patient with no comorbidities. Patients with COPD and > or = 1 other comorbidity had the worst survival rate when compared with all of the other groups.
慢性阻塞性肺疾病(COPD)与接受冠状动脉搭桥手术(CABG)患者的院内死亡率增加有关。长期生存率的情况则了解较少。本研究探讨了COPD对CABG术后生存的影响。
我们对1992年至2001年期间在新英格兰北部连续接受单纯CABG手术的33137例患者进行了一项前瞻性研究。记录与国家死亡指数相链接以获取长期死亡率数据。采用Cox比例风险回归计算风险比(HRs)。患者按以下情况分层:无合并症(无)、COPD、COPD合并其他合并症以及有其他合并症但无COPD。共有131434人年的随访时间,5344例死亡。总体发病率(每100人年的死亡数)为4.1。按组划分,发病率分别为:2.1(无)、4.0(仅COPD)、5.5(其他)和9.4(COPD合并其他合并症;对数秩检验P<0.001)。调整后,仅患有COPD的患者与无合并症患者相比,生存率更差(HR,1.8;95%CI,1.6至2.1;P<0.001)。有其他合并症的患者与无合并症患者相比,生存率更差(HR,2.2;95%CI,2.1至2.4;P<0.001)。COPD合并其他合并症的患者与无合并症患者相比,长期生存率最差(HR,3.6;95%CI,3.3至3.9;P<0.001)。
与无合并症的患者相比,仅患有COPD的患者长期生存率显著降低。与所有其他组相比,患有COPD且合并≥1种其他合并症的患者生存率最差。